- Quotes
- Dashboard
- Chart
- Historical Prices
- Options
- News & PR
- News
- Market Currents
- Press Releases
- Coverage
- Cramer
- Top Analysts
- Business Intelligence
- Transcripts
- Events
- Key Developments
- Earnings
- History & Projected
- Consensus
- Peer Earnings
- Filings
- SEC Filings
- Annual Report
- Financials
- Income Statement
- Balance Sheet
- Cash Flow
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
RIGL Market Currents
more »
-
May 1 Rigel Pharmaceuticals (RIGL): Q1 EPS of -$0.32 beats by $0.01. Revenue of $750K beats by $120K. (PR)
Comment![Earnings, Healthcare]
RIGL in Focus
more »
RIGL Related Articles
more »
RIGL News
more »
-
at CNBC.com (Dec 1, 2011)
-
at CNBC.com (Apr 21, 2011)
RIGL Press Releases and Filings
more »
-
PR Newswire (May 16, 2012)
-
PR Newswire (May 1, 2012)
-
PR Newswire (Jan 5, 2012)
-
PR Newswire (Dec 7, 2011)
RIGL Latest Transcript
more »
Currently, there are no transcripts for RIGL.
RIGL Cramer
more »
Currently, there are no Cramer articles on RIGL.
RIGL Instablog posts
more »
RIGL vs. ETF Alternatives
Company Description
Currently, there's no company description for RIGL.
